Eli Lilly | LLY - Revenu Net

Prix De L'Action
930.80
Variation Quotidienne
-58.32 -5.90%
Mensuellement
-8.80%
Annuel
13.17%
Q1 Prévisions
955.33




Revenu Net Changement Date
AbbVie USD 1.82B 1.63B 2025-12
Abbott USD 1.78B 132M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Biogen USD 466.5M 168.3M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Coherus Biosciences USD -56.57M 5.87M 2025-03
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
J&J USD 5.12B 36M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merck USD 2.96B 2.82B 2025-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Novartis USD 3.93B 113M 2025-09
Novo Nordisk DKK 26.89B 388M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sanofi EUR -801M 3.6B 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Zoetis USD 603M 118M 2025-12